Phillips Medisize

Phillips Medisize is a provider of outsource design, development and technology-driven manufacturing, with a primary focus in the medical device and diagnostics, drug delivery, primary pharmaceutical packaging, and commercial markets. 85% of the company’s total revenue coming from drug delivery, medical device and diagnostic products, such as:

• Disposable insulin pens
• Glucose meters
• Speciality inhalation drug delivery devices
• Single-use surgical devices
• Consumable diagnostic components.

Phillips Medisize operates on a partnering business model, and works with pharmaceutical, biopharmaceutical, consumable diagnostic and medical device companies with the purpose of increasing speed-to-market. The company provides in-house expertise and specialist facilities in order to achieve this, including the use of its Technology Accelerators. In drug delivery, Phillips Medisize works with delivery devices and combination products, in some cases operating as the legal manufacturer. Phillips Medisize was the first company to deliver an FDA approved connected health system to the market. The company has Class 7 and Class 8 certified cleanrooms and complies with all relevant standards and guidelines.

Phillips Medisize Corporation is headquartered in Hudson, WI, US, and employs over 5,400 people in 17 production locations throughout the US, Europe, Mexico and China. The company also operates a global design network with hubs in Hudson (WI, US) and Struer (Denmark) supported by a global network in North America, Europe and China. Phillips Medisize was formed by the merger of US-based Phillips Plastics and European-based Medisize in 2011. In 2016, Phillips Medisize acquired Medicom Innovation Partner (UK) and Injectronics (US) to expand its capabilities, and was subsequently acquired by Molex, an affiliate of Koch Industries, later that year.

What's this?